Skip to content

Revvity RVTY Price / book

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Danaher logo
DanaherDHR
2.5×-0.4×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.5×-0.5×
WAT
Waters CorporationWAT
1.9×-9.3×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×
Illumina logo
IlluminaILMN
+1.7×

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Calculated from Revvity’s reported figures.

Based on the most recent quarter.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's price / book?
Revvity (RVTY) reported price / book of 1.4× in Q1 2026.
How has Revvity's price / book changed year-over-year?
Revvity's price / book decreased by 18.1% year-over-year, from 1.7× to 1.4×.
What is the long-term trend for Revvity's price / book?
Over 5 years (2020 to 2025), Revvity's price / book has grown at a -20.8% compound annual growth rate (CAGR), from 4.8× to 1.5×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.